Современные подходы к лечению почечно-клеточного рака

1. Jacqmin D., van Poppel H., Kirkali Z., Mickisch G. Renal cancer // Eur. Urol. — 2001;39:361—369.

2. Kirkali Z., Yorukoglu K. Premalignant lesions in the kidney // Scientific World J. — 2001;1:855—867.

3. Pehlivan S., Koyuncuoglu M., Pehlivan M. et al. Premalignant lesions of the kidney share the same genetics changes as conventional renal cell carcinoma // World J. Urol. — 2004;22(2):120—123.

4. Kirkali Z., Lekili M. Renal cell carcinoma: new prognostic factors? // Curr. Opin. Urol. — 2003;13(6):433—438.

5. Kirkali Z. Limits of cure by surgery in renal cell carcinoma / In Kurth K.H., Mickisch G.H., Schroeder F.H. eds // Renal, Bladder and Prostate Cancer, an Update. Bath: Parthenon Publishing Group. — 1999:15—22.

6. Lam J.S., Shvarts O., Pantuck A.J. Changing concepts in the surgical management of renal cell carcinoma // Eur. Urol. — 2004;45(6):692—705.

7. Tsui K.H., Shvarts O., Barbaric Z. et al. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies // J. Urol. — 2000;163:437—441.

8. Blom J.H., van Poppel H., Marechal J.M. et al. Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC Randomized Phase III Protocol 30881 // Eur. Urol. — 1999;36:570—575.

9. Minervini A., Lilas L., Morelli G. et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? // BJU Int. — 2001;88(3):169—172.

10. Fenn N.J., Gill I.S. The expanding indications for laparoscopic radical nephrectomy // BJU Int. — 2004;94(6):761—765.

11. Portis A.J., Yan Y., Landman J. et al. Long term follow up after laparoscopic radical nephrectomy // J. Urol. — 2002;167:1257—1262.

12. Desai M.M., Strzempkowski B., Matin S.F. et al. Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy // J. Urol. — 2005;173(1):38—41.

13. Shuford M.D., McDougall E.M., Chang S.S. et al. Complications of contemporary radical nephrectomy: compari son of open vs. laparoscopic approach // Urol. Oncol. — 2004;22(2):121—126.

14. Van Poppel H., Baert L.V. Nephron sparing surgery / In Petrovich Z., Baert L., Brady L.W. eds, Carcinoma of the Kidney and Testis, Rare Urological Malignancies. Innovations in Management. — Berlin, Heidelberg: Springer—Verlag. — 1999:79—93.

15. Nieder A.M., Taneja S.S. The role of partial nephrectomy for renal cell carcinoma in contemporary practice // Urol. Clin. North. Am. — 2003;30(3):529—542.

16. Hafez K.S., Fergany A.F., Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging // J. Urol. — 1999;162(6):1930—1933.

17. Lerner S.E., Hawkins C.A., Blute M.L. et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery // J. Urol. — 1996;155(6):1868—1873.

18. Fergany A.F., Hafez K.S., Novick A.C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup // J. Urol. — 2000;163(2):442—445.

19. Lee C.T., Katz J., Shi W. et al. Surgical management of renal tumors 4 cm. or less in a contemporary cohort // J. Urol. — 2000;163(3):730—736.

20. Belldegrun A., Tsui K.H., deKernion J.B., Smith R.B. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-nodemetastasis staging system // J. Clin. Oncol. — 1999;17(9):2868—2875.

21. Thrasher J.B., Robertson J.E., Paulson D.F. Expanding indications for conservative renal surgery in renal cell carcinoma // Urology. — 1994;43(2):160—168.

22. Vermooten V. Indications for conservative surgery in certain renal tumors: a study based on the growth pattern of the cell carcinoma // J. Urol. — 1950;64(2):200—208.

23. Hafez K.S., Novick A.C., Butler B.P. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location // J. Urol. — 1998;159(4):1156—1160.

24. Blackley S.K., Ladaga L., Woolfitt R.A., Schellhammer P.F. Ex situ study of the effectiveness of enucleation in patients with renal cell carcinoma // J. Urol. — 1988;140(1):6—10.

25. Robson C.J. Radical nephrectomy for renal cell carcinoma // J. Urol. — 1963;89:37—42.

26. McKiernan J., Simmons R., Katz J., Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy // Urology. — 2002;59(6):816—820.

27. Lau W.K., Blute M.L., Weaver A.L. et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney // Mayo Clin. Proc. — 2000;75(12):1236—1242.

28. Novick A.C. Laparoscopic and partial nephrectomy // Clin. Cancer. Res. — 2004; 15;10(18 Pt 2):6322S—6327S.

29. Gill I.S., Matin S.F., Desai M.M. et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients // J. Urol. — 2003;170(1):64—68.

30. Seifman B.D., Hollenbeck B.K., Wolf J.S. Jr. Laparoscopic nephron-sparing surgery for a renal mass: 1-year minimum follow-up // J. Endourol. — 2004;18(8):783—786.

31. Hwang J.J., Walther M.M. Update on minimally invasive approaches to kidney tumors // Curr. Urol. Rep. — 2004;5(1):13—18.

32. Cestari A., Guazzoni G., dell'Acqua V. et al. Laparoscopic cryoablation of solid renal masses: intermediate term followup // J. Urol. — 2004;172(4 Pt 1):1267—1270.

33. Kirkali Z., Tuzel E., Mungan M.U. Recent advances in kidney cancer and metastatic disease // BJU Int. — 2001;88(8):818—824.

34. Huland E., Heinzer H. Renal cell carcinoma — innovative medical treatments // Curr. Opin. Urol. — 2004;14(4):239—244.

35. Bukowski R.M. Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma // Semin. Oncol. — 2000;27:204—212.

36. McDermott D.F., Regan M.M., Clark J.I. et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma // J. Clin. Oncol. — 2005; 1;23(1):133—141

37. Waters J.S., Moss C., Pyle L. et al. Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma // Br. J. Cancer. — 2004; 15;91(10):1763—1768.

38. Nanus D.M., Garino A., Milowsky M.I. et al. Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma // Cancer. — 2004; 1;101(7):1545—1551.

39. Lipton A., Colombo-Berra A., Bukowski R.M. et al. Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid // Clin. Cancer Res. — 2004; 15;10(18 Pt 2):6397—6403.

40. Aass N., De Mulder P.H., Mickisch G.H. et al. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951) // J. Clin. Oncol. — 2005; 20;23(18):4172—4178.

41. Rackley R., Novick A., Klein E. et al. The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma // J. Urol. — 1994;152:1399—1403.

42. Mickisch G.H., Garin A., Madej M., Sylvester R. Tumour nephrectomy plus interferon-a is superior to interferon-alone in metastatic renal cell carcinoma // J. Urol. — 2000; 163: 778A.

43. Staehler G., Brkovic D. The role of radical surgery for renal cell carcinoma with extension into the vena cava // J. Urol. — 2000;163:1671—1675.

44. Stadler W.M., Kuzel T., Shapiro C. et al. A multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal cell carcinoma // J. Clin. Oncol. — 1999;17:2541—2545.

45. De Mulder P.H., van Herpen C.M., Mulders P.A. Current treatment of renal cell carcinoma // Ann. Oncol. — 2004;15, Suppl. 4: 319—328.

46. Oosterwijk E., Divgi C.R., Brouwers A. et al. Monoclonal antibody-based therapy for renal cell carcinoma // Urol. Clin. North Am. — 2003;30(3):623—631.